News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) to Fully Buy Cellzome AG for $99 Million



5/15/2012 7:48:56 AM

Research-based pharmaceutical and healthcare company GlaxoSmithKline PLC (GSK.LN) said Tuesday it has entered into an agreement to buy the 80.02% of Cellzome AG it doesn't already own for GBP61 million in cash. Cellzome, a privately owned company with laboratories in Cambridge, U.K., and Heidelberg, Germany, will become part of GSK's R&D organization. Cellzome's proteomics technologies can be used throughout drug discovery from screening to selectivity profiling of compounds in different cells and also in patient samples.

Read at Fox News
Read at Telegraph
Read at Reuters
Read at News Release
Read at InPharm.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES